Created to Cure Infections
About Dinfectome
Founded in 2018, Dinfectome is a high-tech enterprise focusing on the research, development and service of clinical molecular testing technology for pathogenic microorganisms, with a research and development and commercial operation team of hundreds of people from top-ranked domestic and international universities and multidisciplinary intersections. Currently, Dinfectome has established cooperation with over 1,500 clinical experts in more than 700 core hospitals. Meanwhile, we have set up medical testing centers in Nanjing, Shanghai, Guangzhou, Beijing and Chengdu to improve the timeliness of reports and meet clinical needs.
Development Path
Information Centre
11/ 21/ 2023
Dinfectome Receives Chinese NMPA Approval for New NGS Sequencer

Dinfectome Inc., announced on Tuesday that its DIFSEQ-200 sequencer gained approval from the Chinese National Medical Products Administration (NMPA) on November 8, 2023

08/ 09/ 2023
Data Field Academic | mNGS Rapid Diagnosis of Copperophilus Girardi Infected COVID-19 Rehabilitation Patient Case Report

Introduction In July 2023, Professor Han Wei’s team from Qingdao Hospital of Rehabilitation University (Qingdao Municipal Hospital) published an article in the International Journal of Infectious Diseases (IF=8.4) that Copperophilus Girardi in convalescent patients with COVID-19 A case report of an infection caused by a medium, to explore the clinical value of mNGS technology in the rapid diagnosis of rare pathogen infection.

12/ 14/ 2022
Dickinson Academy | mNGS confirms that Corynebacterium striatae causes infective endocarditis after kidney transplantation

In August 2022, the team of Professor Tian Ye from the Urology Department of Beijing Friendship Hospital Affiliated to Capital Medical University, in cooperation with Difei Medical, published a case report in the journal Infection and Drug Resistance (IF=4.1772), describing a case of Corynebacterium striata. Diagnosis and treatment process of a 35-year-old male patient with congenital valvular endocarditis.Metagenomic sequencing of mitral valve and neoplastic tissue during treatment revealed Corynebacterium striata infection.

Dinfectome Online

About Dinfectome

Telephone: + 86 - 4006362325
E-mail: marketing@dinfectome.com
Address: No.128 Huakang Road, Jiangbei New District, Nanjing, Jiangsu Province, China
Leave a Message

Follow Us

Copyright© 2023 Difei Medical Technology (Nanjing) Co., Ltd. Su ICP No. 20046744-2 All rights reserved | Sitemap | Privacy Policy | Leadong support